Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

8.26
Delayed Data
As of Jul 02
 -0.26 / -3.05%
Today’s Change
1.46
Today|||52-Week Range
9.89
+422.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.00245.0K
 
 
Depreciation And Amortization90.0K98.0K67.0K68.0K
 
 
 
 
 
 
Operating ExpensesGross Income-90.0K-98.0K-67.0K--
 
 
 
 
General Expenses6.8M6.6M7.2M7.8M
 
 
 
 
 
Research And Development5.3M5.3M5.5M6.0M
 
 
 
 
 
Total Operating Expenses6.9M6.7M7.3M7.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.9M-6.7M-7.3M-7.7M
 
 
 
 
 
Interest Expense On Debt360.0K286.0K144.0K0.00
 
 
 
 
Other Expenses-31.0K-14.0K-3.0K-3.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.3M-7.0M-7.4M-7.7M
 
 
 
 
 
Net Income-7.3M-7.0M-7.4M-7.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.5M22.7M22.9M27.6M
 
 
 
 
 
Shares To Calculate EPS Diluted21.5M22.7M22.9M27.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34-$0.31-$0.32-$0.28
 
 
 
 
 
EPS Diluted-$0.34-$0.31-$0.32-$0.28
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account